Poland – Pharmaceutical products – DOSTAWA PRODUKTÓW FARMACEUTYCZNYCH STOSOWANYCH W RAMACH PROGRAMÓW LEKOWYCH I CHEMIOTERAPII - 146 PAKIETÓW

Wojewódzki Szpital Zespolony W Płocku · Poland government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

October 19, 2026
Response Due
Active
Status

Opportunity Overview

Abemacyclib tabl. | Alpelisibum tabl. | Atezolizumabum 1200 mg koncentrat | Atezolizumabum 1875 mg, roztwór do wstrzykiwań | Brigatinibum tabl. | Capivasertibum tabl. | Cemiplimabum 350mg, koncentrat | Crizotinibum tabl. | Durwalumab koncentrat | Fruquintinibum kaps. | Ipilimumabum koncentrat | Mirvetuximabum soravtansinum koncentrat | Nintedanibum kaps. | Niraparibum kaps. | Nivolumabum koncentrat | Olaparibum tabl. | Osimertinibum tabl. | Palbociclibum tabl. | Pembrolizumabum 100 mg, koncentrat | Pertuzumabum 420 mg, koncentrat | Ribociclibum tabl. | Ripretinibum tabl. | Rucaparibum tabl. | Sacituzumabum govitecanum 200 mg, proszek | Serplulimabum | Sotorasibum tabl. | Talazoparibum kaps. | Tislelizumabum 100 mg, koncentrat | Trastuzumabum 600 mg, roztwór | Trastuzumab deruxtecan 100 mg, proszek | Trastuzumabum emtansinum proszek | Trastuzumabum + Pertuzumabum roztwór | Trifluridinum+ Tipiracilum | Tucatinibum tabl. | Abirateroni acetas tabl. | Acidum levofolinicum roztwór | Acidum zoledronicum | Aflibercept koncentrat | Anagrelidum | Bendamustinum hydrochloridum 100 mg | Bevacizumabum koncentrat | Bleomycini sulphas | Bortezomibum 3,5 mg | Cabazitaxelum koncentrat, 60mg | Cabazitaxelum koncentrat, 45 mg, 50 mg | Capecitabinum tabl. | Carboplatinum koncentrat | Cetuximabum roztwór | Chlorambucilum tabl. | Cisplatinum koncentrat | Cladribinum roztwór | Cyclophosphamidum koncentrat lub proszek | Cyclophosphamidum tabl. 50 mg | Dacarbazinum proszek | Darbepoetinum alfa roztwór | Denosumabum 120 mg, roztwór | Dexamethasoni phosphas 4 mg/ml roztwór | Dexamethasoni phosphas 8mg/ml, roztwór | Docetaxelum koncentrat | Doxorubicinum koncentrat lub roztwór | DOXORUBICINUM LIPOSOMANUM PEGYLATUM koncentrat | Doxorubicinum 50 mg; proszek, dyspersja i rozpuszczalnik | Epirubicini hydrochloridum koncentrat lub roztwór | Etoposidum, koncentrat | Fluorouracilum roztwór | Fulvestrantum roztwór | Gefitynibum tabl. | Gemcitabinum koncentrat | Ifosfamidum proszek | Imatynibum |...

This Poland Health Services opportunity is one most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyWojewódzki Szpital Zespolony W Płocku
CountryPoland
CategoryHealth Services
PublishedSeptember 18, 2026
Procurement stageRequest for Proposal (RFP)
Response dueOctober 19, 2026
StatusOpen — accepting responses
Original languagePolish — members read it in their own language
Official sourceView original notice
Last verifiedSeptember 18, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Poland

Poland – Software package and information systems
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products
Poland – Pharmaceutical products

See every Poland Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Poland Health Services intelligence report in your inbox

A personalized report on Poland Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.